livemint.com
52%
873
Piramal Glass sees surge in vial demand due to COVID-19
BENGALURU : India's Piramal Glass Pvt Ltd has seen a 30% jump in sales of specialty vials used to bottle medicines in the June quarter, led by a surge in demand as more drugs are being made to combat the COVID-19 pandemic, a senior executive told Reuters.The privately held Mumbai-based firm, part of Indian billionaire Ajay Piramal's drugs-to-financial services conglomerate, is projecting a 30% bump in revenue from Type 1 borosilicate glass vials in 2020-21, Piramal Glass Vice-Chairman Vijay Shah said last week."There has been an upsurge in demand because of some adjunct therapies being used in hospitals for COVID patients," Shah said.Shah did not specify revenue figures for Piramal's vials business, but assured it was in a position to